NCT05552014

Brief Summary

explore objective indicators of the efficacy of natural psychotherapy in the treatment of disorders such as obsessive-compulsive disorder

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 21, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 23, 2022

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

December 30, 2024

Status Verified

December 1, 2024

Enrollment Period

3.6 years

First QC Date

September 21, 2022

Last Update Submit

December 24, 2024

Conditions

Keywords

obsessive-compulsive disordernatural psychotherapy

Outcome Measures

Primary Outcomes (1)

  • Obsessive-compulsive symptoms

    Using the score of Yale-Brown Obsessive-Compulsive Scale as the primary outcome, a decrease in score of ≥35% was considered a 'response to treatment', also referred to as a 'full response', and a decrease in score of ≥25% was considered a 'partial response'

    Baseline, week 4, week 8

Secondary Outcomes (5)

  • Self-reported obsessive-compulsive symptoms

    Baseline, week 4, week 8

  • Cognitive inhibition

    Baseline, week 8

  • Behavioral inhibition

    Baseline, week 8

  • ERP components associated with cognitive function

    Baseline, week 8

  • rest fMRI in Obsessive-compulsive patients

    Baseline, week 8

Study Arms (2)

Natural Psychotherapy

ACTIVE COMPARATOR

Intervention using natural psychotherapy for OCD patients for two to three hours once a week for eight weeks

Behavioral: Natural Psychotherapy

Mental Health Education

PLACEBO COMPARATOR

Mental health education was given to another group of OCD patients for two hours once a week for eight weeks

Behavioral: Mental Health Education

Interventions

Natural psychotherapy is based on "Morita therapy" and is a psychotherapy that fully reflects the characteristics of Chinese culture, taking into account the Chinese cultural background and actual clinical characteristics.

Natural Psychotherapy

Mental Health Education Seminar

Mental Health Education

Eligibility Criteria

Age15 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • were between 16 and 55 years old;
  • were diagnosed with OCD by an experienced psychiatrist utilizing the Structured Clinical Interview for DSM-5 (SCID);
  • had an illness duration of at least 12 months;
  • were able to participate in the entire trial and face-to-face on-site assessment

You may not qualify if:

  • pregnant or breastfeeding;
  • suffered from organic brain diseases or severe physical illness;
  • had a history of substance or alcohol abuse
  • were at high risk of suicide

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Anhui Mental Health Center

Hefei, Anhui, 230022, China

RECRUITING

Institute of Psychology, Chinese Academy of Sciences

Beijing, China, 100096, China

RECRUITING

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Study Officials

  • Xiang Y Zhang, M.D, Ph.D

    Institute of Psychology, Chinese Academy of Science

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Xiang Y Zhang, M.D., Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The patient was assigned to either the intervention group or the control group, but the control group would also receive treatment after a two-month waiting period. Therefore, the patient was only informed whether they would be participating in the first or second intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 21, 2022

First Posted

September 23, 2022

Study Start

May 1, 2022

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

December 30, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Data with be available on request

Locations